Heart Protection In large-scale clinical trials like LEADER, GLP-1s were shown to lower the risk of heart attack, stroke, and cardiovascular death
Aug 16: After two prior setbacks, Ipsens palovarotene finally earned FDA approval to treat fibrodysplasia ossificans progressive (FOP), the first treatment for the ultra-rare bone disease
One of the most consistent shifts reported by GLP-1 users is altered taste perception, particularly a heightened sensitivity to sweetness and a loss of appeal for previously enjoyable foods, especially those high in sugar. Food makers can reinvigorate taste buds for GLP-1 users There are tips and tricks food makers can harness to help make food more enjoyable for GLP-1 drug users
Public-facing audit seals, routine fairness checks, and a track record of settled disputes establish confidence
Mary-Elizabeth Patti, MD The exciting explosion of clinical and research advances related to incretins, including the single-, dual- or upcoming triple-agonist approaches, will likely continue over the next few years